These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11494869)

  • 1. Exploiting anthracycline scaffold for designing DNA-targeting agents.
    Priebe W; Fokt I; Przewloka T; Chaires JB; Portugal J; Trent JO
    Methods Enzymol; 2001; 340():529-55. PubMed ID: 11494869
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-based design of a new bisintercalating anthracycline antibiotic.
    Chaires JB; Leng F; Przewloka T; Fokt I; Ling YH; Perez-Soler R; Priebe W
    J Med Chem; 1997 Jan; 40(3):261-6. PubMed ID: 9022792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug--DNA interactions.
    Chaires JB
    Curr Opin Struct Biol; 1998 Jun; 8(3):314-20. PubMed ID: 9666327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new bisintercalating anthracycline with picomolar DNA binding affinity.
    Portugal J; Cashman DJ; Trent JO; Ferrer-Miralles N; Przewloka T; Fokt I; Priebe W; Chaires JB
    J Med Chem; 2005 Dec; 48(26):8209-19. PubMed ID: 16366602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticancer drug-DNA complex: femtosecond primary dynamics for anthracycline antibiotics function.
    Qu X; Wan C; Becker HC; Zhong D; Zewail AH
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14212-7. PubMed ID: 11724924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the effects of daunorubicin and WP631 on transcription.
    Portugal J; Martín B; Vaquero A; Ferrer N; Villamarín S; Priebe W
    Curr Med Chem; 2001 Jan; 8(1):1-8. PubMed ID: 11172687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis-daunomycin hydrazones: interactions with DNA.
    Phillips DR; Brownlee RT; Reiss JA; Scourides PA
    Invest New Drugs; 1992 Jul; 10(2):79-88. PubMed ID: 1500269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
    Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
    J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and characterization of polyintercalating ligands.
    Guelev VM; Cubberley MS; Murr MM; Lokey RS; Iverson BL
    Methods Enzymol; 2001; 340():556-70. PubMed ID: 11494870
    [No Abstract]   [Full Text] [Related]  

  • 11. Sp1 transcription factor as a target for anthracyclines: effects on gene transcription.
    Mansilla S; Portugal J
    Biochimie; 2008 Jul; 90(7):976-87. PubMed ID: 18226599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
    Horton D; Khare A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the entropic structural transition of DNA complexes formed with intercalating drugs.
    Rocha MS
    Phys Biol; 2009 Jun; 6(3):036013. PubMed ID: 19525574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Anthracycline 3'-azido-epirubicin with Calf Thymus DNA via Spectral and Molecular Modeling Techniques.
    Cui F; Niu X; Li L; Zhang P; Zhang G
    J Fluoresc; 2015 Jul; 25(4):1109-15. PubMed ID: 26109510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction model for anthracycline activity against DNA topoisomerase II.
    Moro S; Beretta GL; Dal Ben D; Nitiss J; Palumbo M; Capranico G
    Biochemistry; 2004 Jun; 43(23):7503-13. PubMed ID: 15182192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
    Cardozo MG; Hopfinger AJ
    Mol Pharmacol; 1991 Dec; 40(6):1023-8. PubMed ID: 1758437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the modified daunorubicin WP401 adjacent to a T-G base pair induces the reverse Watson-Crick conformation: crystal structures of the WP401-TGGCCG and WP401-CGG[br5C]CG complexes.
    Dutta R; Gao YG; Priebe W; Wang AH
    Nucleic Acids Res; 1998 Jun; 26(12):3001-5. PubMed ID: 9611247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anthracycline antibiotics 10-epi-oxaunomycin and 10-epi-11-deoxyoxaunomycin.
    Johdo O; Nishida H; Okamoto R; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1995 Oct; 48(10):1153-8. PubMed ID: 7490224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling to study DNA intercalation by anti-tumor drugs.
    Neidle S; Jenkins TC
    Methods Enzymol; 1991; 203():433-58. PubMed ID: 1762566
    [No Abstract]   [Full Text] [Related]  

  • 20. Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs.
    Kaczorowska A; Lamperska W; Frączkowska K; Masajada J; Drobczyński S; Sobas M; Wróbel T; Chybicka K; Tarkowski R; Kraszewski S; Podbielska H; Kałas W; Kopaczyńska M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.